NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. PRPO, today announced it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,125,000 shares of the Company’s common stock and pre-funded warrants to purchase 319,445 shares of…Read More
Precipio Inc Announces Pricing of 2 Million Registered Direct Offering and Concurrent Private Placement Precipio NASDAQPRPO
